Literature DB >> 3365660

AIDS-related lymphoid neoplasia. The Memorial Hospital experience.

D A Lowenthal1, D J Straus, S W Campbell, J W Gold, B D Clarkson, B Koziner.   

Abstract

The clinical features and laboratory results of 63 patients with or at risk for AIDS with lymphoid neoplasias seen from November 1980 through November 1986 are reviewed. Forty-three had systemic non-Hodgkin's lymphoma (NHL), nine had primary large cell lymphomas of the brain, 11 had Hodgkin's disease (HD), and one had plasmacytoma evolving to myeloma. Those with systemic NHL included 40 (93%) with intermediate or high-grade histologies, 35 (81%) with advanced stage (III, IV), and 28 (65%) with extranodal disease at presentation (predominantly marrow and meninges). Overall survival was short (median, 10.5 months from diagnosis) with the majority of deaths attributable to AIDS-related opportunistic infections (OI). However, 17 patients with diffuse NHL achieved a complete clinical remission, and nine now have been disease-free for more than 1 year (median follow-up, 28 months; range, 12 to 73 months). Early stage and lack of systemic symptoms were features associated with prolonged disease-free survival. Primary brain NHL was a uniformly lethal manifestation of AIDS, being diagnosed at postmortem in seven of nine severely immunosuppressed homosexual men. As with NHL, a propensity towards advanced disease and extranodal involvement was also observed in HD, suggesting that the atypical clinical behavior of HD may be an additional epiphenomenon of AIDS. This experience tends to argue for the use of intensive therapy in at least some patients with AIDS-related systemic NHL since it has resulted in a proportion of long-term disease-free survivors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3365660     DOI: 10.1002/1097-0142(19880601)61:11<2325::aid-cncr2820611130>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

Review 1.  HIV-associated lymphomas.

Authors:  D J Straus
Journal:  Curr Oncol Rep       Date:  2001-05       Impact factor: 5.075

Review 2.  Paediatric oncology in developing countries.

Authors:  G Prindull
Journal:  Eur J Pediatr       Date:  1991-08       Impact factor: 3.183

3.  Mastoiditis, lymphoma, and AIDS.

Authors:  T Lowry; L Raja; A Verghese
Journal:  West J Med       Date:  1998-09

Review 4.  Pathogenesis of AIDS-related lymphomas: molecular and histogenetic heterogeneity.

Authors:  G Gaidano; A Carbone; R Dalla-Favera
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

5.  Immunocytochemical analysis of lymph node aspirates in patients with human immunodeficiency virus infection.

Authors:  J Oertel; B Oertel; H Lobeck; D Huhn
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

Review 6.  Central nervous system prophylaxis in non-Hodgkin lymphoma: who, what, and when?

Authors:  Chan Yoon Cheah; John F Seymour
Journal:  Curr Oncol Rep       Date:  2015-06       Impact factor: 5.075

7.  AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization.

Authors:  S J Hamilton-Dutoit; G Pallesen; M B Franzmann; J Karkov; F Black; P Skinhøj; C Pedersen
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

Review 8.  Malignant tumours in patients with HIV infection.

Authors:  U Tirelli; S Franceschi; A Carbone
Journal:  BMJ       Date:  1994-04-30

Review 9.  HIV-mediated B-lymphocyte activation and lymphomagenesis.

Authors:  J G Monroe; L E Silberstein
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

10.  Primary uveal B immunoblastic lymphoma in a patient with AIDS.

Authors:  P Hofman; A Le Tourneau; F Negre; J F Michiels; J Diebold
Journal:  Br J Ophthalmol       Date:  1992-11       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.